MUC16 and congestive heart failure: Furthermore, prospective studies such as the BIOSTAT-CHF Study underscore CA125’s potential in differentiating intravascular versus extravascular congestion, while emerging hypotheses suggest that CA125 may even serve as a future therapeutic target in cardiometabolic disorders [43].